Gapping up
In reaction to strong earnings/guidance: YGE +33.2%, XCRA +8.1%
M&A news: CXRX +5.9% (attributed to Apollo talks (WSJ reported last week that Apollo may still be interested but Blackstone and Carlyle walked away)), ACAD +2.6% (UK Daily Mail story circulating that lists potential bidders), GRPN +1.4% (announces Groupon Indonesia to be acquired by KFit; Groupon to be strategic shareholder of KFit)
Select Biotech/Pharma names showing strength after presenting at ASCO over the weekend: JUNO +7.1%, ONTY +6.2%, CLDW +5.3%, PBYI +5.2%, KITE +5%, EXEL +4.1%, ARRY +3.2%, ARIA +1.3%
Select metals/mining stocks trading higher: RIO +3.3%, BBL +3.2%, VALE +3%, BHP +2.9%, CLF +2.8%, FCX +2.3%, AA +1.2%, MT +1%
Select oil/gas related names showing strength: SDRL +3.5%, CHK +3.2%, STO +2.2%, WLL +2%
Other news: ADAP +69.3% (presents data from clinical studies of NY-ESO-1 SPEAR), VBLT +35% (Phase 2 VB-111 results in recurrent glioblastoma (rGBM) meets primary endpoint), LC +3.9% (reports that NY's regulators have stepped up their investigation into online lenders), OVAS +3.7% (seeing modest rebound following last week's weakness following stock offering), YNDX +3.2% (still checking), PLX +3.2% (initiates PRX-102 global Phase III clinical trial of Fabry Disease to support United States and European Filings), IDI +2.2% (announces business update on idiCORE; has on-boarded over 2,800 users), LGIH +1.5% (reports home closings for May rose 69% YoY), AVXL +1.3% (Shared clinical phenotypes and underlying pathophysiology of Autism-Related Disorders such as Fragile X and Rett syndrome), VRX +1% (WSJ previews earnings)
Analyst comments: JAZZ +3.9% (initiated with a Buy at Goldman), HZNP +2.8% (initiated with a Buy at Goldman), CNHI +2.7% (added to Conviction Buy List at Goldman), WMT +1.1% (upgraded to Buy from Hold at Jefferies)